211 related articles for article (PubMed ID: 29604146)
21. Type XVII collagen (BP180) can function as a cell-matrix adhesion molecule via binding to laminin 332.
Van den Bergh F; Eliason SL; Giudice GJ
Matrix Biol; 2011 Mar; 30(2):100-8. PubMed ID: 21034821
[TBL] [Abstract][Full Text] [Related]
22. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
[TBL] [Abstract][Full Text] [Related]
23. Junctional epidermolysis bullosa of late onset explained by mutations in COL17A1.
Yuen WY; Pas HH; Sinke RJ; Jonkman MF
Br J Dermatol; 2011 Jun; 164(6):1280-4. PubMed ID: 21466533
[TBL] [Abstract][Full Text] [Related]
24. Molecular complexity of the cutaneous basement membrane zone.
Uitto J; Pulkkinen L
Mol Biol Rep; 1996; 23(1):35-46. PubMed ID: 8983017
[TBL] [Abstract][Full Text] [Related]
25. New versatile monoclonal antibodies against type XVII collagen endodomain for diagnosis and subtyping COL17A1-associated junctional epidermolysis bullosa.
Yuen WY; Di Zenzo G; Jonkman MF; Pas HH
J Eur Acad Dermatol Venereol; 2016 Aug; 30(8):1426-7. PubMed ID: 26334130
[No Abstract] [Full Text] [Related]
26. C-Terminal Processing of Collagen XVII Induces Neoepitopes for Linear IgA Dermatosis Autoantibodies.
Toyonaga E; Nishie W; Izumi K; Natsuga K; Ujiie H; Iwata H; Yamagami J; Hirako Y; Sawamura D; Fujimoto W; Shimizu H
J Invest Dermatol; 2017 Dec; 137(12):2552-2559. PubMed ID: 28842325
[TBL] [Abstract][Full Text] [Related]
27. Deletion of the cytoplasmatic domain of BP180/collagen XVII causes a phenotype with predominant features of epidermolysis bullosa simplex.
Huber M; Floeth M; Borradori L; Schäcke H; Rugg EL; Lane EB; Frenk E; Hohl D; Bruckner-Tuderman L
J Invest Dermatol; 2002 Jan; 118(1):185-92. PubMed ID: 11851893
[TBL] [Abstract][Full Text] [Related]
28. Autoantibodies of non-inflammatory bullous pemphigoid hardly deplete type XVII collagen of keratinocytes.
Imafuku K; Iwata H; Kamaguchi M; Izumi K; Natsuga K; Ujiie H; Nishie W; Shimizu H
Exp Dermatol; 2017 Dec; 26(12):1171-1174. PubMed ID: 28266727
[TBL] [Abstract][Full Text] [Related]
29. BP180/type XVII collagen: its role in acquired and inherited disorders or the dermal-epidermal junction.
Zillikens D; Giudice GJ
Arch Dermatol Res; 1999 Apr; 291(4):187-94. PubMed ID: 10335914
[TBL] [Abstract][Full Text] [Related]
30. Collagen XVII: a shared antigen in neurodermatological interactions?
Seppänen A
Clin Dev Immunol; 2013; 2013():240570. PubMed ID: 23878581
[TBL] [Abstract][Full Text] [Related]
31. BP180/Collagen XVII: A Molecular View.
Tuusa J; Kokkonen N; Tasanen K
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830116
[TBL] [Abstract][Full Text] [Related]
32. Type XVII collagen interacts with the aPKC-PAR complex and maintains epidermal cell polarity.
Watanabe M; Kosumi H; Osada SI; Takashima S; Wang Y; Nishie W; Oikawa T; Hirose T; Shimizu H; Natsuga K
Exp Dermatol; 2021 Jan; 30(1):62-67. PubMed ID: 32970880
[TBL] [Abstract][Full Text] [Related]
33. Collagen XVII deficiency alters epidermal patterning.
Wang Y; Kitahata H; Kosumi H; Watanabe M; Fujimura Y; Takashima S; Osada SI; Hirose T; Nishie W; Nagayama M; Shimizu H; Natsuga K
Lab Invest; 2022 Jun; 102(6):581-588. PubMed ID: 35145203
[TBL] [Abstract][Full Text] [Related]
34. Premature termination codons are present on both alleles of the bullous pemphigoid antigen 2/type XVII collagen gene in five Austrian families with generalized atrophic benign epidermolysis bullosa.
Darling TN; McGrath JA; Yee C; Gatalica B; Hametner R; Bauer JW; Pohla-Gubo G; Christiano AM; Uitto J; Hintner H; Yancey KB
J Invest Dermatol; 1997 Apr; 108(4):463-8. PubMed ID: 9077475
[TBL] [Abstract][Full Text] [Related]
35. The 120-kDa soluble ectodomain of type XVII collagen is recognized by autoantibodies in patients with pemphigoid and linear IgA dermatosis.
Roh JY; Yee C; Lazarova Z; Hall RP; Yancey KB
Br J Dermatol; 2000 Jul; 143(1):104-11. PubMed ID: 10886143
[TBL] [Abstract][Full Text] [Related]
36. Tissue Destruction in Bullous Pemphigoid Can Be Complement Independent and May Be Mitigated by C5aR2.
Karsten CM; Beckmann T; Holtsche MM; Tillmann J; Tofern S; Schulze FS; Heppe EN; Ludwig RJ; Zillikens D; König IR; Köhl J; Schmidt E
Front Immunol; 2018; 9():488. PubMed ID: 29599777
[TBL] [Abstract][Full Text] [Related]
37. The intracellular domain of BP180/collagen XVII is intrinsically disordered and partially folds in an anionic membrane lipid-mimicking environment.
Tuusa J; Koski MK; Ruskamo S; Tasanen K
Amino Acids; 2020 Apr; 52(4):619-627. PubMed ID: 32219587
[TBL] [Abstract][Full Text] [Related]
38. A novel active mouse model for bullous pemphigoid targeting humanized pathogenic antigen.
Ujiie H; Shibaki A; Nishie W; Sawamura D; Wang G; Tateishi Y; Li Q; Moriuchi R; Qiao H; Nakamura H; Akiyama M; Shimizu H
J Immunol; 2010 Feb; 184(4):2166-74. PubMed ID: 20089696
[TBL] [Abstract][Full Text] [Related]
39. Generation and characterization of monoclonal antibodies against the intracellular domain of hemidesmosomal type XVII collagen.
Olaru F; Mihai S; Petrescu I; Zillikens D; Sitaru C
Hybridoma (Larchmt); 2006 Jun; 25(3):158-62. PubMed ID: 16796463
[TBL] [Abstract][Full Text] [Related]
40. Mutations in the 180-kD bullous pemphigoid antigen (BPAG2), a hemidesmosomal transmembrane collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa.
McGrath JA; Gatalica B; Christiano AM; Li K; Owaribe K; McMillan JR; Eady RA; Uitto J
Nat Genet; 1995 Sep; 11(1):83-6. PubMed ID: 7550320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
